fluphenazine depot has been researched along with Dyskinesia, Drug-Induced in 44 studies
fluphenazine decanoate : The prodrug of fluphenazine, an antipsychotic drug used for the symptomatic management of psychosis in patients with schizophrenia.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage equivalency of haloperidol decanoate (1." | 6.66 | A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. ( Annable, L; Campbell, W; Chouinard, G, 1989) |
| "This study evaluated the feasibility and impact of gradually reducing relatively high doses of fluphenazine decanoate by one-half for chronically impaired, poor inner-city patients with schizophrenia." | 5.07 | A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. ( Egan, GJ; Gloersen, BA; Inderbitzin, LB; Lewine, RR; Scheller-Gilkey, G; Swofford, CD; Vidanagama, BP; Waternaux, C, 1994) |
| "In an attempt to begin to establish minimum effective dosage requirements for the maintenance treatment of schizophrenia, we undertook a double-blind comparison of low-dose fluphenazine decanoate (1." | 5.05 | Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates. ( Kane, JM; Ramos-Lorenzi, J; Reardon, G; Rifkin, A; Sarantakos, S; Schiebel, D; Woerner, M, 1983) |
| " The dosage equivalency of haloperidol decanoate (1." | 2.66 | A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. ( Annable, L; Campbell, W; Chouinard, G, 1989) |
| " There was no significant difference in survival when the clinician was permitted to make a dosage adjustment up to 10 mg in the low-dose group and 50 mg in the higher-dose group when the patient demonstrated evidence of a symptomatic exacerbation." | 2.66 | Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. ( Lebell, M; Marder, SR; May, PR; McKenzie, J; Mintz, J; Van Putten, T, 1987) |
| "Haloperidol was given first in doses of 1." | 1.27 | Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. ( Domino, EF, 1985) |
| "281 newly admitted female schizophrenic patients were treated with high dosage fluphenazine decanoate intramuscularly, starting with 250 mg per injection together with antiparkinsonian and antidepressant drugs." | 1.26 | Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate. ( Nagy, C; Steiner, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (65.91) | 18.7374 |
| 1990's | 11 (25.00) | 18.2507 |
| 2000's | 4 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajarethinam, R | 1 |
| Dziuba, J | 1 |
| Manji, S | 1 |
| Pizzuti, A | 1 |
| Lachover, L | 1 |
| Keshavan, M | 1 |
| Miller, DD | 1 |
| McCormick, SE | 1 |
| Stoessl, AJ | 1 |
| Schiff, AA | 1 |
| Kane, JM | 2 |
| Woerner, M | 2 |
| Weinhold, P | 1 |
| Wegner, J | 1 |
| Kinon, B | 1 |
| Bartels, M | 1 |
| Riffel, B | 1 |
| Stöhr, M | 1 |
| Waddington, JL | 2 |
| Cross, AJ | 1 |
| Gamble, SJ | 1 |
| Bourne, RC | 1 |
| Oyewumi, LK | 1 |
| Lapierre, YD | 1 |
| Gray, R | 1 |
| Batth, S | 1 |
| Gelfand, R | 1 |
| Siris, SG | 1 |
| Rifkin, A | 2 |
| Reardon, GT | 1 |
| November, M | 1 |
| Reardon, G | 1 |
| Sarantakos, S | 1 |
| Schiebel, D | 1 |
| Ramos-Lorenzi, J | 1 |
| Glazer, WM | 1 |
| Perényi, A | 1 |
| Arató, M | 1 |
| Shear, MK | 1 |
| Frances, A | 1 |
| Weiden, P | 1 |
| McCreadie, R | 1 |
| Mackie, M | 1 |
| Morrison, D | 1 |
| Kidd, J | 1 |
| Russell, N | 1 |
| Landmark, J | 1 |
| Merskey, H | 1 |
| Turpin, T | 1 |
| Csernansky, JG | 1 |
| Grabowski, K | 1 |
| Cervantes, J | 1 |
| Kaplan, J | 1 |
| Yesavage, JA | 1 |
| Steiner, S | 1 |
| Nagy, C | 1 |
| Gall, JA | 1 |
| Drummer, OH | 1 |
| Landgren, AJ | 1 |
| Inderbitzin, LB | 1 |
| Lewine, RR | 1 |
| Scheller-Gilkey, G | 1 |
| Swofford, CD | 1 |
| Egan, GJ | 1 |
| Gloersen, BA | 1 |
| Vidanagama, BP | 1 |
| Waternaux, C | 1 |
| Shedlack, KJ | 1 |
| Soldato-Couture, C | 1 |
| Swanson, CL | 1 |
| Sachdev, P | 3 |
| Saharov, T | 1 |
| Cathcart, S | 1 |
| Linn, GS | 1 |
| Lifshitz, K | 1 |
| O'Keeffe, RT | 1 |
| Lee, K | 1 |
| Camp-Lifshitz, J | 1 |
| Soni, SD | 1 |
| Sampath, G | 1 |
| Shah, A | 1 |
| Krska, J | 1 |
| Bergen, J | 1 |
| Kitchin, R | 1 |
| Berry, G | 1 |
| Tang, WM | 1 |
| Mitchell, IJ | 1 |
| Crossman, AR | 1 |
| Liminga, U | 1 |
| Andren, P | 1 |
| Gunne, LM | 1 |
| McClelland, HA | 1 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Marder, SR | 2 |
| Midha, KK | 1 |
| Van Putten, T | 2 |
| Aravagiri, M | 1 |
| Hawes, EM | 1 |
| Hubbard, JW | 1 |
| McKay, G | 1 |
| Mintz, J | 2 |
| Jann, MW | 1 |
| Fidone, GS | 1 |
| Hernandez, JM | 1 |
| Amrung, S | 1 |
| Davis, CM | 1 |
| Chouinard, G | 1 |
| Annable, L | 1 |
| Campbell, W | 1 |
| Faraone, SV | 1 |
| Green, AI | 1 |
| Brown, W | 1 |
| Yin, P | 1 |
| Tsuang, MT | 1 |
| Neehall, J | 1 |
| Cooper, SJ | 1 |
| Doherty, MM | 1 |
| King, DJ | 1 |
| Domino, EF | 1 |
| Kolakowska, T | 2 |
| Williams, AO | 2 |
| Ardern, M | 2 |
| Reveley, MA | 1 |
| Genz, A | 1 |
| Munetz, MR | 1 |
| Ginchereau, EH | 1 |
| Toenniessen, LM | 1 |
| Lebell, M | 1 |
| McKenzie, J | 1 |
| May, PR | 1 |
| Curson, DA | 1 |
| Barnes, TR | 1 |
| Bamber, RW | 1 |
| Platt, SD | 1 |
| Hirsch, SR | 1 |
| Duffy, JC | 1 |
| Cadieux, RJ | 1 |
| Kales, JD | 1 |
| Kales, A | 1 |
| Biever, J | 1 |
| Mann, LD | 1 |
| Rapisarda, V | 1 |
| Bonomo, V | 1 |
| Parisi, R | 1 |
1 review available for fluphenazine depot and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
10 trials available for fluphenazine depot and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Topics: Adult; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy | 1983 |
Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; | 1983 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Double | 1994 |
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
Topics: Adult; Akathisia, Drug-Induced; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doubl | 1991 |
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Ac | 1989 |
Neuroleptic dose reduction in persistently psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluph | 1989 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.
Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu | 1987 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Dys | 1985 |
34 other studies available for fluphenazine depot and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Sch | 2009 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fema | 2003 |
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug | 2003 |
Fluphenazine decanoate and tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Humans | 1982 |
A prospective study of tardive dyskinesia development: preliminary results.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Fem | 1982 |
[Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Flupenth | 1982 |
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Haloper | 1983 |
Abnormal involuntary movements in patients on long-acting neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Dose-Response Relationship, | 1983 |
Fluphenazine and tardive dyskinesia.
Topics: Delayed-Action Preparations; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fluphenazine; H | 1984 |
Suicide associated with akathisia and depot fluphenazine treatment.
Topics: Adult; Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Psychomotor Ag | 1983 |
Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
Topics: Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans | 1982 |
Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Humans; M | 1982 |
A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
Topics: Adult; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Fluspirilene; Humans; Ma | 1982 |
Fluphenazine decanoate and tardive dyskinesia: a possible association.
Topics: Adult; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Mal | 1981 |
Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate.
Topics: Age Factors; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Humans; Recurrence; | 1981 |
Death due to benzhexol toxicity.
Topics: Bronchopneumonia; Cause of Death; Death, Sudden; Dyskinesia, Drug-Induced; Empyema, Pleural; Fatal O | 1995 |
Rapidly progressive tardive dyskinesia in AIDS.
Topics: Adult; AIDS Dementia Complex; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Fluphenazine; H | 1994 |
The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Delayed-Action Preparations; Disease Models, Animal; Dy | 1999 |
Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
Topics: Aggression; Animals; Antipsychotic Agents; Cebus; Dyskinesia, Drug-Induced; Female; Fluphenazine; Lo | 2001 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, | 1992 |
Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; F | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskines | 1992 |
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
Topics: Animals; Autoradiography; Blood Glucose; Brain; Brain Mapping; Cebus; Densitometry; Deoxyglucose; Dy | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
Tardive oculogyric crisis and obsessional thoughts.
Topics: Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Middle Aged; Obsessive-Compulsive Disorder; | 1991 |
Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; F | 1989 |
Tardive dyskinesia in outpatients on depot phenothiazine.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; | 1989 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Thera | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixo | 1985 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Ind | 1986 |
[Tardive dystonia--a case report on therapy and metaphylaxis].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Fluphena | 1988 |
Tardive dyskinesia complicated by hyperthyroidism.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Psychotic Disorders; Thyrotoxicosis | 1987 |
Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.
Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Dyskinesia, Drug-Induced; Fluphenazine; | 1985 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dy | 1985 |